RSSNewsletterSiteMapFeedback

Home · Weather · Forum · Learning Chinese · Jobs · Shopping
Search This Site
China | International | Business | Government | Environment | Olympics/Sports | Travel/Living in China | Culture/Entertainment | Books & Magazines | Health
Home / Top News Tools: Save | Print | E-mail | Most Read
China shuts down 300 drug & medical instrument manufacturers
Adjust font size:

China has shut down 300 drug and medical instrument manufacturers for inferior quality products during a national campaign that has been ongoing since last July, said China's drug watchdog in Beijing on Monday.

"The campaign to correct malpractice in the pharmaceutical industry is showing results," said Wu Zhen, deputy director of the State Food and Drug Administration (SFDA), at a press conference.

By October, about 900 fake drug producers were dug out and 440 cases were handed over to the prosecutors while 279 persons faced criminal charges, he said.

During the campaign, inspectors have examined more than 29,000 types of drugs and examined over 148,000 drug registration files and 26,000 files for medical instruments.

About 7,300 pharmacy companies withdrew their application for drug approvals during the campaign, Wu said, adding that the quality of drugs, waiting for approval, has greatly improved although the number of applications has dropped.

The inspectors also found 1,100 already approved drugs and medical appliances that had been illegally approved.

"Producers of blood products and vaccines were high on the inspection agenda," Wu said. About 1,300 inspectors were sent to specific pharmaceutical firms to tighten supervision.

The administration also verified the companies winning certificates of Good Manufacturing Practice (GMP) and withdrew 150 such certificates, he said.

To regulate the medicine distribution, more than 900 drug retailers and wholesalers' sales licenses were withdrawn for selling drugs they should not sell.

Meanwhile, around 180 drugs and medical instruments were banned from sale after being advertised illegally.

The Panama medicine deaths have reflected managerial differences between different countries, Wu Zhen also said.

"Management on imported drugs varies among different countries, " said Wu.

"This will inevitably result in blank points in management that may enable some companies to take advantage of the loophole," he added.

China has been strict with management regarding chemical medical materials, said Wu.

According to China's law on drug management, Chinese companies are not allowed to produce medical materials that could be directly used in medicine unless they have got a license and a certificate number from the proper drug authorities.

And China has set down specific regulations regarding imported drug management, Wu said, noting that no drug would be admitted into the country before it is proved to be safe.

In some countries, however, imported drugs need not be approved, the official said.

To address the differences, Wu said that the SFDA has signed an agreement with pertinent organizations inside the European Union focused on strengthening drug management, and has reached consensus with the Food and Drug Administration (FDA) of the United States in areas of drug and medical apparatus safety.

China's actions follow the deaths of dozens of people in Panama after taking medicine that was made in China. A Chinese company shipped 11,349 kg of "TD glycerin" to Spain in 2003, where it was then sold on to Panama.

The product, "TD glycerin" is an industrial solvent containing the toxic diethylene glycol. It was later found to be linked to dozens of deaths in Panama from tainted medicine.

Chinese quality officials have said that "TD glycerin" is a misleading label because it could be mistaken for glycerin, a sweetener commonly used in drugs. China has shut down the Taixing Glycerin Factory, the producer of "TD glycerin."

But Chinese quality officials stressed that the Panamanian merchants were mainly responsible for the tragedy because they changed the scope of use and shelf life of this product.

The Chinese company confirmed with the Spanish company that the product could not be used as a pharmaceutical in China and that the product's shelf life was one year rather than four years, according to Chinese officials.

At the press conference, Wu also warned both domestic and foreign drug trading companies not to import from illegal Chinese exporters or drug producers in order to ensure drug safety.

(Xinhua News Agency December 4, 2007)

Tools: Save | Print | E-mail | Most Read

Comment
Username   Password   Anonymous
 
China Archives
Related >>
- China blacklists unqualified medical devices
- SFDA Uncovers Medical Equipment Malpractice
- China to Tighten Control of Medical Appliances
- Illegal Online Drugstores Warned
Most Viewed >>
-Winter storms leave Chinese dark, cold, hungry in 'dead cities'
-Millions stranded in holiday havoc
-Taiwan authorities to raise 'referenda'
-Snow havoc causes US$7.5bn in losses
-Taklamakan Desert experiences record snow
SiteMap | About Us | RSS | Newsletter | Feedback

Copyright ? China.org.cn. All Rights Reserved E-mail: webmaster@china.org.cn Tel: 86-10-88828000 京ICP證 040089號

主站蜘蛛池模板: 欧美乱人伦人妻中文字幕| 翁熄系列回乡下| 国产精品线在线精品| 一二三四在线观看高清| 日本猛妇色xxxxx在线| 亚洲丶国产丶欧美一区二区三区| 波多野结衣伦理片在线观看| 免费看片aⅴ免费大片| 色一乱一伦一区一直爽| 国产成人无码精品久久二区三区 | 免费看又黄又无码的网站| 老司机亚洲精品| 国产产无码乱码精品久久鸭| 国产叼嘿久久精品久久| 国产精品bbwbbwbbw| 67194熟妇在线观看线路| 在线一区二区观看| a级毛片免费观看在线播放| 小雄和三个护士阅读| 中文字幕一区二区人妻性色| 日韩一级欧美一级在线观看| 五月天婷婷精品视频| 欧日韩在线不卡视频| 亚洲国产欧美日韩第一香蕉| 欧美最猛性xxxx| 亚洲欧美日韩综合久久久久| 波多野结衣女上司| 人人爽人人澡人人高潮| 看一级毛片**直播在线| 免费污污视频在线观看| 精品中文字幕乱码一区二区| 加勒比色综合久久久久久久久 | 国产麻豆va精品视频| 99精品国产99久久久久久97| 天天看天天爽天天摸天天添| www五月婷婷| 好吊妞视频免费观看va| √天堂资源在线| 好吊妞欧美视频免费| аⅴ资源中文在线天堂| 妞干网2018|